Authors:
Gasparini, G
Bonso, A
Themistoclakis, S
Giada, F
Raviele, A
Citation: G. Gasparini et al., Bow-energy internal cardioversion in patients with long-lasting atrial fibrillation refractory to external electrical cardioversion: results and long-term follow-up, EUROPACE, 3(2), 2001, pp. 90-95
Authors:
Gasparini, G
Perugini, M
Vetrano, S
Cassoni, A
Fini, G
Citation: G. Gasparini et al., Angiodysplasia with osteohypertrophy affecting the oromaxillofacial area: Clinical findings, J CRANIOF S, 12(5), 2001, pp. 485-489
Citation: G. Gasparini, Clinical significance of determination of surrogate markers of angiogenesis in breast cancer, CR R ONC H, 37(2), 2001, pp. 97-114
Authors:
Dittadi, R
Meo, S
Fabris, F
Gasparini, G
Contri, D
Medici, M
Gion, M
Citation: R. Dittadi et al., Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments, INT J B MAR, 16(2), 2001, pp. 87-96
Authors:
Gridelli, C
Cigolari, S
Gallo, C
Manzione, L
Ianniello, GP
Frontini, L
Ferrau, F
Robbiati, SF
Adamo, V
Gasparini, G
Novello, S
Perrone, F
Citation: C. Gridelli et al., Activity and toxicity of gemcitabine and gemcitabine plus vinorelbine in advanced non-small-cell lung cancer elderly patients - Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial, LUNG CANC, 31(2-3), 2001, pp. 277-284
Authors:
Gasparini, G
Biganzoli, E
Bonoldi, E
Morabito, A
Fanelli, M
Boracchi, P
Citation: G. Gasparini et al., Angiogenesis sustains tumor dormancy in patients with breast cancer treated with adjuvant chemotherapy, BREAST CANC, 65(1), 2001, pp. 71-75
Authors:
Gasparini, G
Toi, M
Biganzoli, E
Dittadi, R
Fanelli, M
Morabito, A
Boracchi, P
Gion, M
Citation: G. Gasparini et al., Thrombospondin-l and-2 in node-negative breast cancer: Correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis, ONCOL-BASEL, 60(1), 2001, pp. 72-80
Citation: G. Gasparini et M. Gion, Molecular-targeted anticancer therapy: Challenges related to study design and choice of proper endpoints, CANCER J, 6(3), 2000, pp. 117-131
Authors:
Cascinu, S
Staccioli, MP
Gasparini, G
Giordani, P
Catalano, V
Ghiselli, R
Rossi, C
Baldelli, AM
Graziano, F
Saba, V
Muretto, P
Catalano, G
Citation: S. Cascinu et al., Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer, CLIN CANC R, 6(7), 2000, pp. 2803-2807
Authors:
Cascinu, S
Valenti, A
Amadio, P
Mare, M
Munao, S
Crucitta, E
Raffaele, M
Picone, G
Mesiti, M
Gasparini, G
Citation: S. Cascinu et al., Angiosuppression and chemotherapy: strategies for integrating them in cancer patients, INT J B MAR, 15(2), 2000, pp. 202-202
Authors:
Morabito, A
Bevilacqua, P
Vitale, S
Fanelli, M
Gattuso, D
Gasparini, G
Citation: A. Morabito et al., Clinical management of a case of recurrent apocrine gland carcinoma of thescalp: Efficacy of a chemotherapy schedule with methotrexate and bleomycin, TUMORI, 86(6), 2000, pp. 472-474
Authors:
Gasparini, G
Fanelli, M
Boracchi, P
Morabito, A
Locopo, N
Biganzoli, E
Citation: G. Gasparini et al., Behaviour of metastasis in relation to vascular index in patients with node-positive breast cancer treated with adjuvant tamoxifen, CLIN EXP M, 18(1), 2000, pp. 15-20
Authors:
Biondi, E
Ranieri, G
Nicolo, A
Gasparini, G
Citation: E. Biondi et al., A unique case of eccrine porocarcinoma with pulmonary lymphangitis and pericardial involvement: Biological characterization and clinical aggressiveness, ONCOL-BASEL, 59(3), 2000, pp. 190-195
Authors:
Minischetti, M
Vacca, A
Ribatti, D
Iurlaro, M
Ria, R
Pellegrino, A
Gasparini, G
Dammacco, F
Citation: M. Minischetti et al., TNP-470 and recombinant human interferon-alpha 2a inhibit angiogenesis synergistically, BR J HAEM, 109(4), 2000, pp. 829-837
Authors:
Gridelli, C
Frontini, L
Perrone, F
Gallo, C
Gulisano, M
Cigolari, S
Castiglione, F
Robbiati, SF
Gasparini, G
Ianniello, GP
Farris, A
Locatelli, MC
Felletti, R
Piazza, E
Citation: C. Gridelli et al., Gemcitabine plus vinorelbine in advanced non small cell lung cancer: a phase II study of three different doses, BR J CANC, 83(6), 2000, pp. 707-714
Authors:
Gasparini, G
Toi, M
Miceli, R
Vermeulen, PB
Dittadi, R
Biganzoli, E
Morabito, A
Fanelli, M
Gatti, C
Suzuki, H
Tominaga, T
Dirix, LY
Gion, M
Citation: G. Gasparini et al., Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with eitheradjuvant chemotherapy or hormone therapy, CA J SCI AM, 5(2), 1999, pp. 101-111
Authors:
Toi, M
Gion, M
Saji, H
Asano, M
Dittadi, R
Gilberti, S
Locopo, N
Gasparini, G
Citation: M. Toi et al., Endogenous interleukin-12: Relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinoma, INT J ONCOL, 15(6), 1999, pp. 1169-1175